Despite the fact that the macroeconomic scenario continues to be uncertain and the general situation difficult, the Bank continues to operate efficiently and with great faith in the future and is well prepared, also in terms of its equity, to face up to the forthcoming months, aware that they are… Read More
Npl meeting: the non-performing loan stock will rise to 385 billion Euro in 2021. 34 billion worth of new NPL expected on the market “The new Wave”: the ninth edition of the event organised by Banca Ifis for the NPL and bank restructuring market took… Read More
Milan, 7 August 2020 – Banca Ifis and illimity Bank announce they have finalized a deal involving non-performing loans (“NPL”) for a total Gross Book Value of approximately 266 million euro and related to around 4,000 debtors. Specifically, the portfolio sold by illimity to Ifis NPL, a subsidiary of Banca… Read More
During the first half, business proves to be resilient and the equity position improves despite the difficult context Net profit stands at 37 million Euro, net of adjustments and impairment for 36 million Euro (pretax) as a result of the Covid-19 Improving equity position with an increase of CET1… Read More
Wednesday 30 September 2020 – NPL Meeting will return with a new edition to talk once more about the latest developments in the world of impaired loans during the most important Italian industry event organised by Banca Ifis. The spotlight will focus entirely on the NPL industry: a market that,… Read More
First two months of the year in line with Business Plan targets Solid financial position with an increase in CET1 ratio to 11,12% and liquidity of 1,4 billion Euro Swift, incisive response to Covid-19 Safety and protection of health: 93% of personnel working remotely… Read More
Rome, March 12th, 2020 – The Board of Directors of Banca IFIS met today under the chairmanship of Ernesto Fürstenberg Fassio and approved the draft financial statement for the year 2019 which incorporate the preliminary results as of December 31st, 2019, previously approved by the Board and disclosed to the… Read More
